Unichem Laboratories declared their Q3 FY24 results on 05 Feb, 2024. The topline increased by 43.6% & the profit came at ₹83.99cr.
It is noteworthy that Unichem Laboratories had declared a loss of ₹63.93cr in the previous fiscal year same period.
As compared to the previous quarter, the revenue grew by 4.51%.
The Selling, general & administrative expenses rose by 1.45% q-o-q & increased by 8.33% Y-o-Y.
The operating income was up by 462.69% q-o-q & increased by 202.04% Y-o-Y.
The EPS is ₹5.65 for Q3 FY24, which increased by 162.54% Y-o-Y.
Unichem Laboratories has delivered a 17.78% return in the last 1 week, 40.23% return in the last 6 months, and 38.3% YTD return.
Currently, Unichem Laboratories has a market cap of ₹3952.23 Cr and a 52wk high/low of ₹561.35 & ₹271.65 respectively.
Unichem Laboratories Financials
Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 434.38 | 415.63 | +4.51% | 302.5 | +43.6% |
Selling/ General/ Admin Expenses Total | 98.11 | 96.72 | +1.45% | 90.57 | +8.33% |
Depreciation/ Amortization | 27.86 | 29.45 | -5.42% | 30.78 | -9.5% |
Total Operating Expense | 359.33 | 436.32 | -17.64% | 376.04 | -4.44% |
Operating Income | 75.05 | -20.69 | +462.69% | -73.54 | +202.04% |
Net Income Before Taxes | 83.97 | -21.88 | +483.73% | -61.28 | +237.03% |
Net Income | 83.99 | -24.49 | +442.99% | -63.93 | +231.38% |
Diluted Normalized EPS | 5.65 | -3.48 | +262.23% | -9.03 | +162.54% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.